Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women

Br J Obstet Gynaecol. 1987 Dec;94(12):1199-204. doi: 10.1111/j.1471-0528.1987.tb02322.x.

Abstract

After two control cycles, 13 normally menstruating women were treated from day 5 to 25 of the third consecutive cycle with nomegestrol acetate (NOM Ac) 1.25, 2.5 or 5 mg once a day. Plasma oestradiol, FSH and LH concentrations were assayed daily from day 5 to day 25 and plasma progesterone concentrations from day 12 to day 25. Ovulation was inhibited in every woman; LH and progesterone levels were uniformly depressed. With 5 and 2.5 mg/day, plasma oestradiol remained low with high FSH values. With 1.25 mg/day, oestradiol concentrations reached levels similar to those achieved during the control follicular phase, with a concomitant decrease in FSH secretion. These results show an hypothalamic-pituitary effect and suggest an ovarian action, both responsible for a potentially useful contraceptive property.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Luteinizing Hormone / blood
  • Megestrol*
  • Norpregnadienes / pharmacology*
  • Ovary / drug effects*
  • Ovary / metabolism
  • Ovulation / drug effects
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • Progesterone / blood
  • Progesterone Congeners / pharmacology*

Substances

  • Norpregnadienes
  • Progesterone Congeners
  • Progesterone
  • Estradiol
  • nomegestrol acetate
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Megestrol